INFLIXIMAB EFFECT ON CLINICAL AND LABORATORY ACTIVITY PARAMETERS IN CASES OF VARIOUS JUVENILE ARTHRITIS VARIANTS
<em>The study analyses efficiency and safety of using mono clone antibodies for tumor necrosis factor (infliximab) for children with system (n = 21) and articular (n = 59) juvenile arthritis (JA). Infliksimab was injected intravenously (average dose of 6,8 ± 2,3 mg/kg/per injection) by a stand...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2008-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|